(Q34552882)

3 August 2017

1 reference

title

Identifying disease modifying genes in multiple sclerosis (English)

1 reference

3 August 2017

0 references

1

Orhun H Kantarci

1 reference

3 August 2017

2

Mariza de Andrade

1 reference

3 August 2017

3

Brian G Weinshenker

1 reference

3 August 2017

1 February 2002

1 reference

Journal of Neuroimmunology

3 August 2017

1 reference

3 August 2017

123

1 reference

3 August 2017

144-159

1 reference

3 August 2017

1-2

1 reference

Selected methodological issues in meiotic mapping of obesity genes in humans: issues of power and efficiency

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Relationship between tumour necrosis factor-alpha (TNFalpha) production and a specific multiple sclerosis (MS) associated TNF gene haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A possible new genetic marker associated with a severe course of multiple sclerosis, located on chromosome 2: Km

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Age of onset in siblings concordant for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

APOE genotype is a major predictor of long-term progression of disability in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis in the Orkneys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis in black South Africans and Zimbabweans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis sibling pairs: Clustered onset and familial predisposition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetics of multiple sclerosis [published erratum appears in Hum Mol Genet 1997 Nov;6(12):2189]

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Optic neuritis in familial MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA-typing in multiple sclerosis sibling pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA and heterogeneity of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

APOE epsilon2-4 and -491 polymorphisms are not associated with MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The statistical basis of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or -DQ?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Combined linkage and association sib-pair analysis for quantitative traits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Analysis of an IFN- gamma gene (IFNG) Polymorphism in Multiple Sclerosis in Europe: Effect of Population Structure on Association with Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis in Australia: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Human leukocyte antigen studies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

An immunogenetic heterogeneity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis amongst Chinese in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A Genomewide Screen in Multiplex Rheumatoid Arthritis Families Suggests Genetic Overlap with Other Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association of a myeloperoxidase promoter polymorphism with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Prospects for whole-genome linkage disequilibrium mapping of common disease genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Glutathione S-transferase polymorphisms in MS: their relationship to disability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Clinical demographics of multiplex families with multiple sclerosis. Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

New insights into the immunogenetics of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA-antigens and the prognosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A transmission disequilibrium test for quantitative trait loci

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

IgG allotypes and subclasses in Norwegian patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The future of genetic studies of complex human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Clinical concordance in sibling pairs with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA-DRW4 and prognosis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Clinical outcomes assessment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA and prognosis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Heterogeneity in multiple sclerosis: comparison of clinical manifestations in relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Effect of age at onset and parental disease status on sibling risks for MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Pathology and pathogenesis of demyelinating diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The natural history of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Seeking genes for MS: big risks for big gains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

A comparison of sporadic and familial multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Genetic variation in the B7-1 gene in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

How many diseases does it take to map a gene with SNPs?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

Clinical outcome measures and rating scales in multiple sclerosis trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900481-7

7 January 2021

10.1016/S0165-5728(01)00481-7

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11880159